A groundbreaking discovery at IDWeek 2025 has the potential to revolutionize HIV prevention, and it's all about affordability. Imagine, a life-saving treatment for as little as $25 a year! But here's the catch: it's currently priced at a whopping $28,000 in the US. So, how can we bridge this gap and make HIV prevention accessible to all?
The Power of Lenacapavir
Lenacapavir, a capsid inhibitor, is a game-changer in HIV prevention. It's an injectable treatment that provides incredible protection against HIV infection, and the best part? It only needs to be administered twice a year! This convenience factor is a huge advantage, especially for at-risk populations, as it improves adherence and makes managing HIV a whole lot easier.
The Cost Conundrum
While lenacapavir's approval by the FDA in 2022 and 2025 is a huge step forward, its high cost remains a significant barrier. Researchers from Howard and Liverpool```json
{
